Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 799 results for "alexion pharmaceuticals"

Alexion Pharmaceuticals Given New $222.00 Price Target at Nomu...

Alexion Pharmaceuticals (NASDAQ:ALXN) had its price target lowered by Nomura from $223.00 to $222.00 in a research note issued to investors on Friday. The firm currently has a neutral rating on the stock. A number of other analysts have also ... WKRB News, 17 hours ago
[x]  

40 images for alexion pharmaceuticals

Jutia Group, 2 weeks ago
NewsReality.com, 1 day ago
NewsReality.com, 1 day ago
Hartford Business Journal, 2 weeks ago
American Banking News, 1 month ago
I Stock Analyst, 2 weeks ago
Nasdaq, 1 month ago
One News Page United Kingdom, 1 month ago
Providence Business News, 2 months ago
ETF Channel, 1 month ago
Jutia Group

Alexion Pharmaceuticals (ALXN) Stock Fell Today on Missed Earnings, Weak Guidance

Reddit Email Print Reprint NEW YORK ( TheStreet ) -- Alexion Pharmaceuticals ( ALXN - Get Report ) shares closed trading down 1.9% to $184.62 on Thursday following the pharmaceutical company's first quarter earnings miss before the opening ...
 TheStreet.com3 days ago Alexion Pharmaceuticals' (ALXN) CEO David Hallal on Q1 2015 Results - Earnings Call Transcript  Seeking Alpha3 days ago Alexion Pharmaceuticals (ALXN) Q1 2015 Results - Earnings Call Webcast  Seeking Alpha3 days ago Alexion Pharma Q1 Profit Decreases - Quick Facts  RTTNews.com3 days ago
[x]  

Alexion Pharma revenues up 6%; net income off 43%; guidance maintained

News Editor Alexion Pharmaceuticals (NASDAQ:ALXN) Q1 results ($M): Total Revenues (all Soliris): 600.3 (+5.9%); Operating Income: 103.7 (-50.5%); Net Income: 91.3 (-42.7%); EPS: 0.45 (-43.0%); Quick Assets: 1,925.1 (-1.9%). 2015 Guidance: Total ...
 Seeking Alpha3 days ago Alexion Pharmaceuticals misses by $0.05, beats on revenue  Seeking Alpha3 days ago Rayno Portfolio Picks Up On Q1 Results: AMGN, ILMN  Minyanville4 days ago

Watch for Alexion Pharmaceuticals to Potentially Rebound After Falling 1.92% Yesterday

(Comtex SmarTrend(R)) Alexion Pharmaceuticals (NASDAQ:ALXN) traded in a range yesterday that spanned from a low of $179.18 to a high of $186.99. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $180.51 on volume ...
 Individual.com3 days ago Look for Shares of Alexion Pharmaceuticals to Potentially Pullback after Yesterday's 3.15% Rise  Individual.com1 month ago

Short-term Underperformance Detected in Shares of Alexion Pharmaceuticals in the Biotechnology Industry (ALXN, BCRX, INFI, INCY, AMGN)

(Financial News Network On) Below are five companies in the Biotechnology industry that underperformed yesterday on a relative basis. This analysis was compiled based on yesterday's trading activity as we search for stocks that have could possible ...
 Individual.com2 days ago Best Relative Performance in the Biotechnology Industry Detected in Shares of AMAG Pharmaceuticals (AMAG, RGEN, ALXN, AMGN, ARWR)  Comtex SmarTrend1 month ago

Alexion (ALXN) Misses on Q1 Earnings, Maintains Outlook - Tale of the Tape

Alexion Pharmaceuticals (ALXN) focuses on the development and commercialization of life-transforming drugs for treating patients suffering from ultra-rare disorders. Soliris approved for paroxysmal nocturnal hemoglobinuria and atypical hemolytic ...
 Yahoo! Finance3 days ago

Alexion Pharmaceuticals Reaffirms Below Estimates

Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) said it continues to expect 2015 non-GAAP earnings of $5.60 to $5.80 per share on revenue of $2.55 billion to $2.60 billion. The current consensus earnings estimate is $5.88 per share on revenue of $2.62 ...
 Individual.com3 days ago

Profit Expected to Dip for Alexion Pharmaceuticals

Despite an expected dip in profit, analysts are generally optimistic about Alexion Pharmaceuticals as it prepares to reports its first-quarter earnings on Thursday, April 23, 2015. The consensus earnings per share estimate is $1.18 per share. The ...
 Forbes.com4 days ago

PX14A6G - ALEXION PHARMACEUTICALS INC (0000899866) (Subject)

Document Format Files Seq Description Document Type Size 1 eps6222.htm PX14A6G 16411 2 GRAPHIC calpers.jpg GRAPHIC 86342 3 GRAPHIC cityofny.jpg GRAPHIC 210846 4 GRAPHIC annesimpson-sig.jpg GRAPHIC 52703 5 GRAPHIC scottstringer-sig.jpg GRAPHIC 54630 ...
 SEC1 week ago DEF 14A - ALEXION PHARMACEUTICALS INC (0000899866) (Filer)  SEC2 weeks ago

Shares of Alexion Pharmaceuticals Receive a Boost, Up 1.4%

One of today's stocks on the move is Alexion Pharmaceuticals (NASDAQ:ALXN), up 1.4% to $188.27. The S&P is trading fractionally lower to 2,100 and the Dow is trading 0.3% lower
 Individual.com5 days ago Stock Investors Sell Off Shares of Alexion Pharmaceuticals, Down 2.6%  Individual.com1 month ago Traders Sell Shares of Alexion Pharmaceuticals on Strength (ALXN)  SleekMoney1 month ago Traders Sell Alexion Pharmaceuticals on Strength (ALXN)  WKRB News1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - alexion pharmaceuticals
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less